Gene Synthesis Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Gene Synthesis 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  to  the la tes t  repor t  by  IMARC Group,  t i t l ed  "Gene Synthesis  
Market :  Global  Industry  Trends,  Share ,  S ize ,  Growth ,  Opportuni ty  and 
Forecast  2024-2032,"  the  g loba l  gene  syn thes is  marke t  s ize  reached US$ 
2.1  B i l l i on  in  2023.
Report Gene syn thes is  re fe rs  to  the labora to ry  method used  to  c rea te  a  
deoxyr ibonuc le ic  ac id  (DNA)  sequence .  I t  invo lves the ar t i f i c ia l  cons t ruc t ion 
Highlight and of  a  spec i f ic  sequence  o f  nuc leot ides as  compared  to  the ex t rac t ion  o f  
na tura l ly  occur r ing  DNA.  
Description I t  a l lows for  exact  cont ro l  over  the  sequence ,  wh ich  enab les  researchers  to  c reate  genes wi thou t  any unwanted  muta t ions.  I t  i s  commonly  used to  s tudy 
gene funct ion ,  p roduce  p ro te ins ,  or  eng ineer  o rgan isms wi th  new 
capab i l i t i es .
Request  for  a  PDF sample of  th is  report :  
ht tps : / /www. imarcgroup.com/gene-syn thes is -marke t / requestsample
Report Description
Global  Gene Syn thes is  Market  T rends:
The  inc reas ing  pre fe rence fo r  pe rsona l i zed  med ic ines  and new genera t i on  d rugs  and  f o rmu la t i ons  on  account  o f  t he  
su rg ing  p reva lence  o f  ch ron ic  and  l i f es t y le  d iso rde rs ,  such  as  cancer ,  d iabe t es ,  and  A lzhe imer ’s ,  r ep resen ts  one  o f  
t he  m a jo r  f ac t o r s  d r i v ing  t he  need  fo r  gene  syn t hes is  a round t he  wor ld .  Moreover ,  t he  r i s i ng  ge r i a t r i c  popu la t ion ,  
wh ich  i s  suscep t ib l e  t o  such  a i lment s ,  i s  augment ing  t he  marke t  g rowth .  I n  add i t i on ,  t he  g row ing  number  o f  c l i n i ca l  
t r i a l s  by  pharmaceut i ca l  compan ies  and  ex tens i ve  improvemen t s  in  med ica l  i n f ras t ruc tu re  and d iagnos t i c  t echno log ies  
a re  in f luenc ing  the  marke t  pos i t i ve ly .  
Apar t  f rom t h is ,  gene  syn thes i s  f i nds  app l i ca t ion  in  t he  ag r i cu l t u ra l  sec to r  t o  enab le  the  deve lopmen t  o f  c rops  w i th  
des i red  t r a i t s  l i ke  d rough t  res is t ance  or  enhanced nu t r i t i ona l  va lue .  Th is ,  coup led  w i th  the  i nc reas ing  fa rm ing  
ac t i v i t i es  and  r i s ing  adop t ion  o f  o rgan ic  fa rm ing  p rac t i ces ,  i s  s t reng t hen ing  t he  g rowth  o f  t he  marke t .
Look ing  fo rward ,  the  market  va lue  i s  p ro j ec ted  to  reach  US$  8 . 3  B i l l ion  by 2032 ,  expand i ng  a t  a  CAGR o f  
16 .58% dur ing  2024-2032 .
V i ew Report  TOC,  F igures and  Tab les :  h t tps: / / www. i marcgroup .com/gene-syn thes i s-market
Method Insights:
• Sol id-Phase Synthesis
• Chip-Based Synthesis 
• PCR-Based Enzyme Synthesis
 
Services Insights:
• Antibody DNA Synthesis
Report 
• Viral  DNA Synthesis
Segmentation • Others
Application Insights:
• Gene and Cel l  Therapy Development
• Vaccine Development
• Disease Diagnosis
• Others
End Use Insights:
• Biotechnology and Pharmaceutical  Companies
• Academic and Government Research Inst i tutes
• Contract Research Organizations
Regional Insights:
Report • North America
Segmentation • Europe
• Asia-Pacifi c
• Latin America
• Middle East and Afr ica
• ATUM
• Boster Biological  Technology
• Eurofi ns Genomics
• Genewiz Inc.  (Azenta Li fe Sciences)
Competitive 
• Genscript Biotech Corp.
Landscape • Integrated DNA Technologies Inc.
with Key • Merck KGaA
• OriGene Technologies Inc.
Players
• ProMab Biotechnologies Inc.
• ProteoGenix Inc
• Thermo Fisher Scient ifi c Inc.
• Twist Bioscience
How has the global gene synthesis market performed so 
far, and how will it perform in the coming years? 
What are the drivers, restraints, and opportunities in 
the global gene synthesis market? 
What is the impact of each driver, restraint, and 
Key opportunity on the global gene synthesis market? 
Questions What are the key regional markets? 
Answered in 
Which countries represent the most attractive gene 
the Report synthesis market? 
What is the breakup of the market based on the 
method? 
Which is the most attractive method in the gene 
synthesis market? 
What is the breakup of the market based on the 
services?
Which are the most attractive services in the gene 
synthesis market? 
What is the breakup of the market based on the 
application? 
Key Which is the most attractive application in the gene synthesis market? 
Questions What is the breakup of the market based on the end 
use? 
Answered in 
Which is the most attractive end use in the gene 
the Report synthesis market? 
What is the competitive structure of the global gene 
synthesis market? 
Who are the key players/companies in the global gene 
synthesis market?
1     P r e f a c e
2  S c o p e  a n d  M e t h o d o l o g y
2 . 1  O b j e c t i v e s  o f  t h e  S t u d y
2 . 2  S t a k e h o l d e r s
2 . 3  D a t a  S o u r c e s
2 . 3 . 1  P r i m a r y  S o u r c e s
2 . 3 . 2  S e c o n d a r y  S o u r c e s
2 . 4  M a r k e t  E s t i m a t i o n
2 . 4 . 1  B o t t o m - U p  A p p r o a c h
Table of 2 . 4 . 2  T o p - D o w n  A p p r o a c h2 . 5  F o r e c a s t i n g  M e t h o d o l o g y
3  E x e c u t i v e  S u m m a r y
4  G l o b a l  G e n e  S y n t h e s i s  M a r k e t  -  I n t r o d u c t i o n
4 . 1  O v e r v i e w
Contents 4 . 2  M a r k e t  D y n a m i c s4 . 3  I n d u s t r y  T r e n d s
4 . 4  C o m p e t i t i v e  I n t e l l i g e n c e
5  G l o b a l  G e n e  S y n t h e s i s  M a r k e t  L a n d s c a p e
5 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
5 . 2  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6  G l o b a l  G e n e  S y n t h e s i s  M a r k e t  -  B r e a k u p  b y  M e t h o d
6 . 1  S o l i d - P h a s e  S y n t h e s i s
6 . 1 . 1  O v e r v i e w
6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 1 . 3  M a r k e t  S e g m e n t a t i o n
6 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 2  C h i p - B a s e d  S y n t h e s i s
6 . 2 . 1  O v e r v i e w
6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 2 . 3  M a r k e t  S e g m e n t a t i o n
6 . 2 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
       
6 . 3  P C R - B a s e d  E n z y m e  S y n t h e s i s
6 . 3 . 1  O v e r v i e w
6 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 3 . 3  M a r k e t  S e g m e n t a t i o n
6 . 3 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 4  A t t r a c t i v e  I n v e s t m e n t  P r o p o s i t i o n  b y  M e t h o d
7  G l o b a l  G e n e  S y n t h e s i s  M a r k e t  -  B r e a k u p  b y  S e r v i c e s
7 . 1  A n t i b o d y  D N A  S y n t h e s i s
7 . 1 . 1  O v e r v i e w
7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
Table of 7 . 1 . 3  M a r k e t  S e g m e n t a t i o n7 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7 . 2  V i r a l  D N A  S y n t h e s i s
7 . 2 . 1  O v e r v i e w
Contents 7 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )7 . 2 . 3  M a r k e t  S e g m e n t a t i o n
7 . 2 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7 . 3  O t h e r s
7 . 3 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
7 . 3 . 2  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7 . 4  A t t r a c t i v e  I n v e s t m e n t  P r o p o s i t i o n  b y  S e r v i c e s
8  G l o b a l  G e n e  S y n t h e s i s  M a r k e t  -  B r e a k u p  b y  A p p l i c a t i o n
8 . 1  G e n e  a n d  C e l l  T h e r a p y  D e v e l o p m e n t
8 . 1 . 1  O v e r v i e w
8 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
8 . 1 . 3  M a r k e t  S e g m e n t a t i o n
8 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /g ene - sy n t hes i s -m a rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: